Results 141 to 150 of about 62,672 (281)

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström, Henrik Svanström, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Peter Ueda, Björn Pasternak   +10 more
wiley   +1 more source

Strengthening pharmacovigilance through patient reporting: a scoping review of awareness, barriers, and facilitators. [PDF]

J Pharm Policy Pract
Aslam A, Majid HA, Muhammad Boota N, Ghulam Mustafa A, Akhtar SS.   +4 more
europepmc   +1 more source

Bringing Gene Therapy Into Real World Clinical Practice

Haemophilia, EarlyView.
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach, Pratima Chowdary, Margareth C. Ozelo   +2 more
wiley   +1 more source

Tubulointerstitial Nephritis Induced by Adalimumab

Turkish Journal of Nephrology
Yasmine Salem Mahjoubi , Widd Kaabi , Ghozlane Lakhoua , Ahmed Zaiem, Riadh Daghfous , Imen Aouinti, Sihem El Aidli   +6 more
doaj   +1 more source

Estriol Is Likely Not Associated With Mouth Ulcerations in Pharmacovigilance Data. [PDF]

Int Dent J
Böhm R, Herdegen T.
europepmc   +1 more source

Developing a co-produced e-learning programme to support marginalised medically underserved patients [PDF]

, 2019
Gulzar, Nargis, Latif, Asam, Mandane, Baguiasri   +2 more
core   +1 more source

Global Pharmacovigilance of Aesthetic Botulinum Toxin Type A: Analysis of Adverse Event Reports From the USA, Europe, Canada, and Australia. [PDF]

J Cosmet Dermatol
Zargaran A, Zargaran D, Pirayesh A, Woollard A, Mosahebi A.   +4 more
europepmc   +1 more source

Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3‐Month results from the TRIUMPH study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To compare the 3‐month effectiveness of galcanezumab with select traditional oral migraine preventive (TOMP) medications recommended by scientific societies (TOMP efficacy subset) and with the most frequently used individual TOMP medications.
Shivang Joshi, Cristina Tassorelli, Manjit Matharu, Taoufik Alsaadi, Carlos Vallarino, Lars Viktrup, Maurice Vincent, Rebecca L. Robinson   +7 more
wiley   +1 more source

Reclaiming Pharmacovigilance: Bridging the Evidence-Practice Gap in Psychopharmacology. [PDF]

J Eval Clin Pract
De Las Cuevas C.
europepmc   +1 more source

Practice and Determinants of Spontaneous Adverse Drug Reaction Reporting Among Healthcare Professionals: A Multicenter Cross-Sectional Study in Vietnam. [PDF]

Hosp Pharm
Pham ST, Nguyen T, Bui KTN, Tran PTT, Nguyen VT, Tran YH.   +5 more
europepmc   +1 more source